Bristol Myers Gets FDA Priority Review of Opdivo-Chemotherapy Combo in Bladder Cancer

By Colin Kellaher Bristol Myers Squibb won a priority review from the Food and Drug Administration for its application seeking expanded approval of a...

Related Keywords

New York ,United States ,Bristol Myers ,Colin Kellaher ,Bristol Myers Squibb ,Drug Administration ,Myers Squibb ,Article Normal ,Pharmaceuticals ,Cancer Drugs ,Healthcare Life Sciences ,Specialized Drugs Medications ,Regulation Government Policy ,New Products Services ,Product Service Approvals ,Corporate Industrial News ,Products Services ,Cancer ,Political General News ,Chemotherapy Radiotherapy Immunotherapy ,Health ,Medical Conditions ,Medical Treatments Procedures ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Bmy ,Us1101221083 ,Regulation ,Government Policy ,New Products ,Services ,Product ,Service Approvals ,Corporate ,Industrial News ,Products ,Political ,General News ,Chemotherapy ,Radiotherapy ,Immunotherapy ,Medical Treatments ,Procedures ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,